FLUENCE CORPORATION LIMITED — Director's Dealing 2017

Sep 3, 2017

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity: Fluence Corporation Limited (ASX:FLC)

ACN: 127 734 196

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Eytan Levy
Date of last notice	20 July 2017
Date that director ceased to be director	31 August 2017

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

None

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature ofinterestNote: Provide details of the circumstances givingrise to the relevant interestBeneficial owner of OrdinaryShares and Unlisted Optionsheld in the name of ESOPManagement and Trust ServicesLtd.

Number & class of securities(a) 9,267,810 Ordinary Shares(b) 5,000,000 Unlisted Options to acquireOrdinary Shares, consisting of:(i) 1,000,000UnlistedDirectorOptions, exercisable at $0.30,expiring at 18/12/2018;(ii) 1,000,000UnlistedDirectorOptions, exercisable at $0.40,expiring at 18/12/2019;(iii) 1,000,000UnlistedDirectorOptions, exercisable at $0.40,expiring at 18/05/2020;(iv) 1,000,000UnlistedDirectorOptions, exercisable at $0.40,expiring at 18/05/2021;(v) 500,000 Unlisted Options withexercise price of $1.20, expiring at13/7/2021 (4 years from issue),escrowed for 24 months; and(vi) 500,000 Unlisted Options withexercise price of $1.50, expiring at13/7/2021 (4 years from issue),escrowed for 24 months.

Part 3 – Director’s interests in contracts

Detail of contract	Share Exchange and Purchase Agreement,the terms of which were summarised insection13.1(a)oftheCompany’sReplacement Prospectus dated 23 October2015.
Nature of interest	In accordance with the terms of the ShareExchange and Purchase Agreement, a rightto receive Ordinary Shares as deferredconsideration for the acquisition of EmefcyLimited, Israel.
Name of registered holder(if issued securities)	Not applicable

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002

Appendix 3Z Final Director’s Interest Notice

No. and class of securities towhich interest relates	Up to a total of 3,104,551 Ordinary Sharesfollowingsatisfactionofaprescribedmilestone (summarised in section 13.6 of theCompany’s Replacement Prospectus dated23 October 2015).

• See chapter 19 for defined terms.

Appendix 3Z Page 3

11/3/2002